Delivery Order SPE2DR25D3016-SPE2DR26FG2FQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,756.34 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with completion required by November 26, 2025. This firm fixed-price delivery order, issued on November 25, 2025, represents a non-competitive award under DLA's broader pharmaceutical procurement strategy and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,183.77 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen injectors, with a completion date of November 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued on November 7, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a $17,669.62 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors (0.5 ml units), with a completion date of December 17, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $3,550.08 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on November 13, 2025, with completion scheduled for November 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,518.02 to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen injectors on December 12, 2025, with an ultimate completion date of December 15, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $2,720.17 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors. This competitive award, with no set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of November 6, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pen injectors on November 5, 2025, with an ultimate completion date of November 6, 2025. This firm fixed-price contract, issued without set-aside provisions, represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,760.19 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pen injectors on September 25, 2025, with completion targeted for September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,172.35 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-competitive, non-set-aside award. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 5, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $3,069.11 and is structured as a firm fixed price delivery order with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG2FQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,115.76 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on December 15, 2025, with completion scheduled for December 16, 2025. This competitively awarded, firm fixed-price delivery order was placed without a set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive portfolio of medications and medical supplies to support federal military and veteran healthcare systems. As a prime vendor under the DLA pharmaceutical supply chain, the company fulfills orders for brand-name and generic drugs, vaccines, specialty medications, and medical devices across multiple therapeutic categories. This delivery order for Mounjaro, a diabetes medication, exemplifies the company's role in providing critical pharmaceutical commodities to support Defense Health Agency operations and other federal healthcare systems through the flexible SPE2DX contract vehicle, which enables global pharmaceutical supply to military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/14/25 |